{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:48:17Z","timestamp":1761176897107,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.tracli.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T09:14:06Z","timestamp":1479287646000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Benefit in long-term response and mortality of treatment with intravenous immunoglobulin prior to plasmapheresis in peripheral polyneuropathies"],"prefix":"10.1016","volume":"24","author":[{"given":"I.","family":"Parra-Salinas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.P.","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Gracia Pina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Gimeno Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Garc\u00eda-Erce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2016.10.003_bib0105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.nrl.2010.03.006","article-title":"Documento de consenso de la Sociedad Espa\u00f1ola de Neurolog\u00eda sobre el uso de medicamentos en Esclerosis M\u00faltiple: escalado terap\u00e9utico","volume":"25","author":"Merino","year":"2010","journal-title":"Neurologia"},{"key":"10.1016\/j.tracli.2016.10.003_bib0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.tracli.2016.10.003_bib0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u00a0\u2013\u00a0Evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2016.10.003_bib0120","first-page":"CD002063","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"9","author":"Rapha\u00ebl","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tracli.2016.10.003_bib0125","first-page":"CD003906","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"8","author":"Mehndiratta","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tracli.2016.10.003_bib0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: state-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.tracli.2016.10.003_bib0135","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neur"},{"key":"10.1016\/j.tracli.2016.10.003_bib0140","first-page":"356","article-title":"Urgent plasma exchange: how, where and when","volume":"9","author":"Russi","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2016.10.003_bib0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/tme.12205","article-title":"Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products","volume":"25","author":"Howell","year":"2015","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2016.10.003_bib0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.2005.065441","article-title":"Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow-up of 38 cases","volume":"77","author":"Kuwabara","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tracli.2016.10.003_bib0155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000224630","article-title":"Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis","volume":"28","author":"Trebst","year":"2009","journal-title":"Blood Purif"},{"key":"10.1016\/j.tracli.2016.10.003_bib0160","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archneurol.2011.34","article-title":"Beneficial plasma exchange response in central nervous system inflammatory demyelination","volume":"68","author":"Maga\u00f1a","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.tracli.2016.10.003_bib0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.2011.01612.x","article-title":"Treatment of steroid-unresponsive optic neuritis with plasma exchange","volume":"126","author":"Roesner","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.tracli.2016.10.003_bib0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.transci.2013.02.043","article-title":"Therapeutic plasma exchange in treatment of neuroimmunologic disorders: review of 92 cases","volume":"49","author":"Sorgun","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2016.10.003_bib0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0972-2327.144301","article-title":"Plasmapheresis in neurological disorders: experience from tertiary care hospital in South India","volume":"18","author":"Gaafor","year":"2015","journal-title":"Ann Inidian Acad Neurol"},{"key":"10.1016\/j.tracli.2016.10.003_bib0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/tme.12169","article-title":"Comparison on therapeutic effect of plasma exchange and intravenous immunoglobulin for Guillian-Barr\u00e9 syndrome","volume":"25","author":"Ye","year":"2015","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2016.10.003_bib0185","doi-asserted-by":"crossref","first-page":"917","DOI":"10.33588\/rn.3710.2003369","article-title":"Plasmaf\u00e9resis: su utilidad en esclerosis m\u00faltiple y otros procesos desmielinizantes del sistema nervioso central. Estudio observacional","volume":"37","author":"Meca-Lallana","year":"2003","journal-title":"Rev Neurol"},{"key":"10.1016\/j.tracli.2016.10.003_bib0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.medin.2009.03.006","article-title":"Utilidad de la Plasmaf\u00e9resis en cuidados intensivos","volume":"34","author":"Salazar Ramirez","year":"2010","journal-title":"Med Intensiva"},{"key":"10.1016\/j.tracli.2016.10.003_bib0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.transci.2014.08.018","article-title":"Efficacy and safety of plasma exchange: a 11-year single-center experience of 2730 procedures in 317 patients","volume":"51","author":"Cid","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2016.10.003_bib0200","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782016302191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782016302191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:35:59Z","timestamp":1761129359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782016302191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1246782016302191"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2016.10.003","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefit in long-term response and mortality of treatment with intravenous immunoglobulin prior to plasmapheresis in peripheral polyneuropathies","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}